Ziegler Capital Management, LLC Care Dx, Inc. Transaction History

Ziegler Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$20.49 - $39.72 $3.05 Million - $5.92 Million	-149,041 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$28.19 - $46.6 $55,590 - $91,895	-1,972 Reduced 1.31%	149,041 $5.51 Million
Q4 2021 Feb 09, 2022	SELL	$41.2 - $73.6 $137,319 - $245,308	-3,333 Reduced 2.16%	151,013 $6.87 Million
Q3 2021 Oct 27, 2021	BUY	$59.15 - $91.99 $5.46 Million - $8.49 Million	92,286 Added 148.7%	154,346 $9.78 Million
Q2 2021 Jul 21, 2021	SELL	$63.02 - $95.11 $6.17 Million - $9.3 Million	-97,832 Reduced 61.19%	62,060 $14.3 Million
Q1 2021 Apr 29, 2021	SELL	$57.62 - $95.6 $4.17 Million - $6.92 Million	-72,403 Reduced 31.17%	159,892 $10.9 Million
Q4 2020 Feb 05, 2021	BUY	$41.43 - $77.09 $170,235 - $316,762	4,109 Added 1.8%	232,295 $16.8 Million
Q3 2020 Oct 21, 2020	SELL	$30.88 - $37.94 $3.46 Million - $4.25 Million	-112,136 Reduced 32.95%	228,186 $8.66 Million
Q2 2020 Jul 24, 2020	SELL	$18.95 - $35.43 $380,989 - $712,320	-20,105 Reduced 5.58%	340,322 $12.1 Million
Q1 2020 Apr 30, 2020	BUY	$13.94 - $28.25 $5.02 Million - $10.2 Million	360,427 New	360,427 $7.87 Million

215

50.9M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.